Search Results 611-620 of 3953 for ai工作流下载网站,ai写作网,配音ai网站,ai换发型网站,综合ai网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.saweb.com

1. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

   Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

2. Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of Sulfonamide Allergy - Mayo Clinic

   Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...

3. ResearchMatch - Center for Clinical and Translational Science

   Learn how you can access ResearchMatch, a free, secure national registry Mayo Clinic helped develop for people who want to volunteer for clinical research.

4. Mayo Clinic Biobank - Hypertension

   Joseph A. Murray, M.D., has identified in previous research that olmesartan (Benicar), a commonly prescribed blood pressure medication, causes severe ...

5. Evaluation of a Tele-Language Rehabilitation Program - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Deb Balzer | Mayo Clinic News Network - Page 43 of 73

   Millions of people use electronic cigarettes, or vaping devices. While tobacco use remains the largest cause of preventable death and disability in the U.S., ...

7. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Anticipated time on study treatment is 1 year or until disease progression or unacceptable toxicity occurs. Participation eligibility. Participant eligibility ...

8. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   This study observes the clinical efficacy of combining proton SBRT with PD-1 blockade immunotherapy in both the locoregionally recurrent and metastatic settings ...

9. Publications - Jaimin S. Shah, M.D. - Mayo Clinic

   Mitsumoto H, Cheung K, Oskarsson B, Jang GE, Andrews HF, Johnson S, Shah JS, Fernandes JA Jr, Andrews JA, Rao M, McElhiney M. Placebo-Controlled, ...

10. A Study of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Stage II Palliation of Hypoplastic Left Heart Syndrome - Mayo Clinic

    This will help determine the safety and feasibility of using cell-based regenerative therapy as an additional treatment for the management of HLHS.